Immune Checkpoint Inhibitor Essentials: Key Principles, Indications, and Clinical Biomarkers

Download these slides for expert insights on key biologic principles, current indications, and clinically relevant biomarkers for immune checkpoint inhibitors.
Sandip P. Patel, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.10 MB
Released: April 16, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.

Related Content

Interactive algorithm tool with NCCN Guidelines® recommendations for Management of Immune Checkpoint Inhibitor–Related Toxicities v3.2021, from CCO

Released: July 22, 2021

From Clinical Care Options (CCO), download a PDF featuring expert answers to clinician questions on CAR T-cell therapy

person default Caron A. Jacobson, MD Jae H. Park, MD Noopur Raje, MD Released: July 19, 2021

Commentary on most important safety and adherence issues to counsel patients starting BTK inhibitors, from Clinical Care Options (CCO)

Beth Faiman, PhD, MSN, APRN-BC, AOCN Released: July 15, 2021

Slides from Clinical Care Options (CCO) on histology-agnostic biomarker testing to guide therapy for gastrointestinal cancer

John L. Marshall, MD Released: July 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue